SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

Read more breaking news

 

 
News in brief

Prokarium to create new oral vaccine delivery tech

10-Jul-2012
Last updated on 11-Jul-2012 at 13:43 GMT

Prokarium – a biotech company that was formerly part of UK CMO Cobra Biologics spin-out - has bought an oral vaccine technology from Emergent BioSolutions.

The platform includes is a live Salmonella-based typhoid vaccine Typhella and genetic technology spi-VEC developed by Emergent. Prokarium will combine this with its own ORT-vac expression platform to create an oral vaccine delivery platform, named Vaxonella.

Prokarium plans to license the delivery platform to other biotechnology companies, while its in-house team will use it to develop a dual oral vaccine against typhoid and travellers’ diarrhoea.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events

 

Access all events listing

Our events, Events from partners...